⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
RDY News
Dr. Reddy's Laboratories Limited American Depositary Shares
Rituximab Biosimilars Market Trastuzumab Biosimilars Market Research Analysis Report 2026: $6.2 Bn Opportunities, Trends, Competitive Landscape, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035F
globenewswire.com
RDY
FMS
Dr. Reddy's Laboratories Announces Health Canada Approval for Generic Semaglutide Injection in Canada
businesswire.com
RDY
RentRedi Earns Inc. Ranking for Third Consecutive Year as DIY Landlords Prefer its Platform to Run Their Entire Rental Business
globenewswire.com
RDY
Nexus Pharmaceuticals Launches Cyclophosphamide Injection, 2.5 mL and 5 mL
businesswire.com
RDY
AI can now Eliminate 78% of Tax Prep Headaches for Landlords
globenewswire.com
RDY
Adacel Market Research Report 2026: Epidemiology, Pipeline Analysis, Market Insights & Forecasts, 2020-2025, 2025-2030F, 2035F
globenewswire.com
SNY
RDY
Dr. Reddy’s Announces USFDA Acceptance to Review Its Biologics License Application (BLA) for Proposed Interchangeable Biosimilar, Abatacept
businesswire.com
RDY
Lancement du livre « Made in India - The story of Desh Bandhu Gupta, Lupin and Indian Pharma » (Fabriqué en Inde - L'histoire de Desh Bandhu Gupta, de Lupin et de la pharmacie indienne) à Mumbai USA - Français India - English
prnewswire.com
SUN
RDY
Dr. Reddy’s Announces the First-to-Market Launch of Olopatadine Hydrochloride Ophthalmic Solution USP, 0.7% (OTC), the Generic Equivalent of Extra-Strength Pataday ® Once Daily Relief, in the U.S.
businesswire.com
RDY
RentRedi Recognized for Premier Customer Service by National Association of Realtors®
globenewswire.com
RDY